Researchers in South Africa on Tuesday launched clinical trials on the first domestically developed vaccine.

The oral cholera vaccine — developed by the Cape Town-based pharmaceutical firm Biovac — is currently undergoing trials to determine its safety in adults and will be followed by trials to compare it to existing cholera vaccines that are already in the market.